| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.360 | 52.631 | 63.106 | 71.870 | 90.143 | 102.258 | 112.674 | 124.485 | 144.904 | 165.354 |
| Total Income - EUR | 2.360 | 52.631 | 63.106 | 71.870 | 90.143 | 102.258 | 112.674 | 124.614 | 144.905 | 165.793 |
| Total Expenses - EUR | 1.748 | 22.857 | 30.525 | 36.409 | 28.967 | 42.752 | 62.643 | 62.558 | 60.019 | 58.141 |
| Gross Profit/Loss - EUR | 612 | 29.774 | 32.581 | 35.461 | 61.176 | 59.505 | 50.031 | 62.056 | 84.885 | 107.652 |
| Net Profit/Loss - EUR | 541 | 29.247 | 31.956 | 34.742 | 60.275 | 58.550 | 49.040 | 60.835 | 83.465 | 102.678 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 |
Check the financial reports for the company - Edelmar Promed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 41.098 | 35.436 | 28.264 | 20.179 |
| Current Assets | 2.818 | 33.596 | 57.718 | 39.631 | 96.828 | 156.131 | 189.401 | 49.969 | 71.950 | 83.349 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.272 | 3.117 | 8.715 | 26.534 | 96.087 | 94.006 | 183.952 | 49.536 | 67.997 | 80.644 |
| Cash | 546 | 30.479 | 49.003 | 13.097 | 741 | 62.124 | 5.450 | 433 | 3.953 | 2.706 |
| Shareholders Funds | 586 | 29.828 | 56.354 | 34.794 | 94.395 | 151.155 | 196.843 | 60.884 | 83.514 | 102.726 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.232 | 3.768 | 1.365 | 4.837 | 2.433 | 4.976 | 33.657 | 24.522 | 16.700 | 801 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Edelmar Promed Srl